Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. (Q48309971)

10 February 2018

review article

1 reference

title

Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. (English)

1 reference

10 February 2018

0 references

0 references

0 references

0 references

1

1 reference

10 February 2018

author name string

Melck D

series ordinal

2

1 reference

10 February 2018

Bisogno T

series ordinal

3

1 reference

10 February 2018

De Petrocellis L

series ordinal

4

1 reference

10 February 2018

publication date

1 December 1998

1 reference

10 February 2018

published in

Trends in Neurosciences

1 reference

10 February 2018

volume

21

1 reference

10 February 2018

page(s)

521-528

1 reference

10 February 2018

issue

12

1 reference

10 February 2018

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Anandamides: tolerance and cross-tolerance to delta 9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Discriminative stimulus effects of anandamide in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

SR141716A is an inverse agonist at the human cannabinoid CB1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Pharmacology of cannabinoid CB1 and CB2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

The N-acylation-phosphodiesterase pathway and cell signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

A second endogenous cannabinoid that modulates long-term potentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma ‘anandamide amidohydrolase’

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Anandamide may mediate sleep induction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Inhibition by 2-arachidonoylglycerol, a novel type of possible neuromodulator, of the depolarization-induced increase in intracellular free calcium in neuroblastoma x glioma hybrid NG108-15 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Is the cannabinoid CB1 receptor a 2-arachidonoylglycerol receptor? Structural requirements for triggering a Ca2+ transient in NG108-15 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Regulation of a neuronal form of focal adhesion kinase by anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Endocannabinoids: a new class of vasoactive substances

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride].

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Morphine- and anandamide-stimulated nitric oxide production inhibits presynaptic dopamine release.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and anandamide synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Cannabis and endogenous cannabinoid systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

The endogenous cannabinoid receptor agonist anandamide impairs memory in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Long-term synaptic transformation of hippocampal CA1 gamma-aminobutyric acid synapses and the effect of anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

The effects of anandamide on memory consolidation in mice involve both D1and D2 dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Modulation of neurotransmission by cannabinoids in the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Production and physiological actions of anandamide in the vasculature of the rat kidney.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

Characterization of glutamate-induced formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cultured neocortical neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2898%2901283-1

7 January 2021

10.1016/S0166-2236(98)01283-1

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

9881850

1 reference

10 February 2018